AngioSafe, Inc.

medical devices

About

AngioSafe, Inc. is a medical device company based in San Jose, California, focused on developing innovative solutions for cardiovascular interventions. Founded in 2014, the company is dedicated to addressing the complexities and safety challenges associated with treating peripheral and coronary artery disease. AngioSafe is building a pipeline of patented devices that are currently in various stages of preclinical and clinical development. The company’s product offerings include devices designed to enhance procedural safety and effectiveness in complex arterial interventions, particularly for peripheral chronic total occlusion (CTO) crossing systems. AngioSafe is actively engaged in clinical research, including the RESTOR-1 trial, to validate their technologies and prepare for commercial approval. Their target customers are interventional cardiologists and vascular specialists, as well as healthcare providers involved in cardiovascular care.

Technologies

Outlook Microsoft Office 365 GoDaddy Hosting Mobile Friendly Apache Remote

Keywords

peripheral artery disease coronary artery disease complex algorithms catheters safety efficacy design engineering test engineering clinical sciences nonclinical manufacturing quality regulatory quality engineering marketing commercial medical affairs critical limb ischemia device pipeline development peripheral arterial disease medical equipment and supplies manufacturing clinical research clinical collaboration interventional cardiology clinical centers regulatory strategy device regulatory pathway clinical validation coronary intervention devices medical research & development

Location

5215 Hellyer Ave, San Jose, California, United States, 95138-1007

Related Companies

Companies in the same industry